Mendelian Randomization with Incomplete Exposure Data: a Bayesian Approach
Authors:
Teresa Fazia,
Leonardo Egidi,
Burcu Ayoglu,
Ashley Beecham,
Pier Paolo Bitti,
Anna Ticca,
Hui Guo,
Jacob L. McCauley,
Peter Nilsson,
Rosanna Asselta,
Carlo Berzuini,
Luisa Bernardinelli
Abstract:
We expand Mendelian Randomization (MR) methodology to deal with randomly missing data on either the exposure or the outcome variable, and furthermore with data from nonindependent individuals (eg components of a family). Our method rests on the Bayesian MR framework proposed by Berzuini et al (2018), which we apply in a study of multiplex Multiple Sclerosis (MS) Sardinian families to characterise…
▽ More
We expand Mendelian Randomization (MR) methodology to deal with randomly missing data on either the exposure or the outcome variable, and furthermore with data from nonindependent individuals (eg components of a family). Our method rests on the Bayesian MR framework proposed by Berzuini et al (2018), which we apply in a study of multiplex Multiple Sclerosis (MS) Sardinian families to characterise the role of certain plasma proteins in MS causation. The method is robust to presence of pleiotropic effects in an unknown number of instruments, and is able to incorporate inter-individual kinship information. Introduction of missing data allows us to overcome the bias introduced by the (reverse) effect of treatment (in MS cases) on level of protein. From a substantive point of view, our study results confirm recent suspicion that an increase in circulating IL12A and STAT4 protein levels does not cause an increase in MS risk, as originally believed, suggesting that these two proteins may not be suitable drug targets for MS.
△ Less
Submitted 14 February, 2020; v1 submitted 12 February, 2020;
originally announced February 2020.
Bayesian Mendelian Randomization identifies disease causing proteins via pedigree data, partially observed exposures and correlated instruments
Authors:
Teresa Fazia,
Leonardo Egidi,
Burcu Ayoglu,
Ashley Beecham,
Pier Paolo Bitti,
Anna Ticca,
Jacob L. McCauley,
Peter Nilsson,
Carlo Berzuini,
Luisa Bernardinelli
Abstract:
Background
In a study performed on multiplex Multiple Sclerosis (MS) Sardinian families to identify disease causing plasma proteins, application of Mendelian Randomization (MR) methods encounters difficulties due to relatedness of individuals, correlation between finely mapped genotype instrumental variables (IVs) and presence of missing exposures.
Method
We specialize the method of Berzuini…
▽ More
Background
In a study performed on multiplex Multiple Sclerosis (MS) Sardinian families to identify disease causing plasma proteins, application of Mendelian Randomization (MR) methods encounters difficulties due to relatedness of individuals, correlation between finely mapped genotype instrumental variables (IVs) and presence of missing exposures.
Method
We specialize the method of Berzuini et al (2018) to deal with these difficulties. The proposed method allows pedigree structure to enter the specification of the outcome distribution via kinship matrix, and treating missing exposures as additional parameters to be estimated from the data. It also acknowledges possible correlation between instruments by replacing the originally proposed independence prior for IV-specific pleiotropic effect with a g-prior. Based on correlated (r2< 0.2) IVs, we analysed the data of four candidate MS-causing proteins by using both the independence and the g-prior.
Results
95% credible intervals for causal effect for proteins IL12A and STAT4 lay within the strictly negative real semiaxis, in both analyses, suggesting potential causality. Those instruments whose estimated pleiotropic effect exceeded 85% of total effect on outcome were found to act in trans. Analysis via frequentist MR gave inconsistent results. Replacing the independence with a g-prior led to smaller credible intervals for causal effect.
Conclusions
Bayesian MR may be a good way to study disease causation at a protein level based on family data and moderately correlated instruments.
△ Less
Submitted 23 September, 2019; v1 submitted 2 March, 2019;
originally announced March 2019.
